- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Artemis Medicare delivered a robust Q1 FY27 performance. Consolidated revenue jumped 12.7% YoY to ₹287.32 Cr, while EBITDA surged 36.4% YoY to ₹56.44 Cr, driving the margin to 19.6%. Net profit (PAT) soared 48.3% YoY to ₹31.44 Cr, with Diluted EPS at ₹1.98 (+46.7% YoY). Gurugram's IP volumes rose 11.4%, with occupancy reaching 65.7%. High-acuity specialties and international patients (27% of revenue) continue to be key growth drivers.
The company is aggressively expanding its integrated healthcare platform. A new 300+ bed super-specialty hospital in Raipur became operational in July 2026. Plans are firm for a 650+ bed hospital in South Delhi (by Q4 FY29) and a 110-bed facility in Mauritius (FY27). This multi-year capacity expansion aims for ~2,000 beds in 3-5 years, driving operating leverage and long-term earnings growth. Management emphasizes operational excellence and demand visibility for future growth.